These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 28643214)
41. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning. Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313 [TBL] [Abstract][Full Text] [Related]
42. Repeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves. Schaefer A; Treede H; Seiffert M; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L J Cardiothorac Surg; 2016 Jan; 11():2. PubMed ID: 26768837 [TBL] [Abstract][Full Text] [Related]
43. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study. Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039 [TBL] [Abstract][Full Text] [Related]
44. Differences in Frame Geometry Between Balloon-expandable and Self-expanding Transcatheter Heart Valves and Association With Aortic Regurgitation. Rodríguez-Olivares R; Rahhab Z; Faquir NE; Ren B; Geleijnse M; Bruining N; van Mieghem NM; Schultz C; Lauritsch G; de Jaegere PP Rev Esp Cardiol (Engl Ed); 2016 Apr; 69(4):392-400. PubMed ID: 26643771 [TBL] [Abstract][Full Text] [Related]
45. Early Clinical Outcomes of Transcatheter Aortic Valve Replacement in Left Ventricular Outflow Tract Calcification: New-Generation Device vs Early-Generation Device. Nomura T; Maeno Y; Yoon SH; Abramowitz Y; Israr S; Miyasaka M; Kazuno Y; Takahashi N; Kawamori H; Nakamura M; Jilaihawi H; Makkar RR J Invasive Cardiol; 2018 Nov; 30(11):421-427. PubMed ID: 30373952 [TBL] [Abstract][Full Text] [Related]
46. Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients. Shishido K; Yamanaka F; Ochiai T; Yamabe T; Noguchi K; Ota T; Koide Y; Ogino H; Tanaka Y; Saito S Heart Vessels; 2019 Oct; 34(10):1674-1683. PubMed ID: 30993441 [TBL] [Abstract][Full Text] [Related]
47. Transcatheter valve-in-valve implantation (VinV-TAVR) for failed surgical aortic bioprosthetic valves. Wernly B; Zappe AK; Unbehaun A; Sinning JM; Jung C; Kim WK; Fichtlscherer S; Lichtenauer M; Hoppe UC; Alushi B; Beckhoff F; Wewetzer C; Franz M; Kretzschmar D; Navarese E; Landmesser U; Falk V; Lauten A Clin Res Cardiol; 2019 Jan; 108(1):83-92. PubMed ID: 30003366 [TBL] [Abstract][Full Text] [Related]
48. Transcatheter aortic valve implantation with the new balloon-expandable Sapien 3 versus Sapien XT valve system: a propensity score-matched single-center comparison. Nijhoff F; Abawi M; Agostoni P; Ramjankhan FZ; Doevendans PA; Stella PR Circ Cardiovasc Interv; 2015 Jun; 8(6):e002408. PubMed ID: 26033967 [TBL] [Abstract][Full Text] [Related]
49. Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves. Modolo R; Chang CC; Abdelghani M; Kawashima H; Ono M; Tateishi H; Miyazaki Y; Pighi M; Wykrzykowska JJ; de Winter RJ; Ruck A; Chieffo A; van Mourik MS; Yamaji K; Richardt G; de Brito FS; Lemos PA; Al-Kassou B; Piazza N; Tchetche D; Sinning JM; Abdel-Wahab M; Soliman O; Søndergaard L; Mylotte D; Onuma Y; Van Mieghem NM; Serruys PW JACC Cardiovasc Interv; 2020 Jun; 13(11):1303-1311. PubMed ID: 32499020 [TBL] [Abstract][Full Text] [Related]
50. Changes in the Pacemaker Rate After Transition From Edwards SAPIEN XT to SAPIEN 3 Transcatheter Aortic Valve Implantation: The Critical Role of Valve Implantation Height. De Torres-Alba F; Kaleschke G; Diller GP; Vormbrock J; Orwat S; Radke R; Reinke F; Fischer D; Reinecke H; Baumgartner H JACC Cardiovasc Interv; 2016 Apr; 9(8):805-813. PubMed ID: 27017367 [TBL] [Abstract][Full Text] [Related]
51. 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial. Abdel-Wahab M; Neumann FJ; Mehilli J; Frerker C; Richardt D; Landt M; Jose J; Toelg R; Kuck KH; Massberg S; Robinson DR; El-Mawardy M; Richardt G; J Am Coll Cardiol; 2015 Aug; 66(7):791-800. PubMed ID: 26271061 [TBL] [Abstract][Full Text] [Related]
52. The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR. Bjursten H; Nozohoor S; Johansson M; Zindovic I; Appel CF; Sjögren J; Dencker M; Olivecrona G; Harnek J; Koul S; Feldman T; Reardon MJ; Götberg M BMC Cardiovasc Disord; 2017 Jan; 17(1):25. PubMed ID: 28086805 [TBL] [Abstract][Full Text] [Related]
53. Comparison of Edwards SAPIEN 3 versus SAPIEN XT in transfemoral transcatheter aortic valve implantation: Difference of valve selection in the real world. Arai T; Lefèvre T; Hovasse T; Morice MC; Garot P; Benamer H; Unterseeh T; Hayashida K; Watanabe Y; Bouvier E; Cormier B; Chevalier B J Cardiol; 2017 Mar; 69(3):565-569. PubMed ID: 27288330 [TBL] [Abstract][Full Text] [Related]
54. Impact of Different Iterations of Devices and Degree of Aortic Valve Calcium on Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation. Kong WK; van Rosendael PJ; van der Kley F; de Weger A; Kamperidis V; Regeer MV; Marsan NA; Bax JJ; Delgado V Am J Cardiol; 2016 Aug; 118(4):567-71. PubMed ID: 27328953 [TBL] [Abstract][Full Text] [Related]
55. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R; JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609 [TBL] [Abstract][Full Text] [Related]
56. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ; JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401 [TBL] [Abstract][Full Text] [Related]
57. Performance and short-term outcomes of three different transcatheter aortic valve replacement devices in patients with aortic stenosis: A single-center experience. Tzeng YH; Lee YT; Tsao TP; Lee KC; Huang KC; Hsiung MC; Wei J; Yin WH J Chin Med Assoc; 2019 Nov; 82(11):827-834. PubMed ID: 31693532 [TBL] [Abstract][Full Text] [Related]
58. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort. Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976 [TBL] [Abstract][Full Text] [Related]
59. Multicenter evaluation of transcatheter aortic valve replacement using either SAPIEN XT or CoreValve: Degree of device oversizing by computed-tomography and clinical outcomes. Dvir D; Webb JG; Piazza N; Blanke P; Barbanti M; Bleiziffer S; Wood DA; Mylotte D; Wilson AB; Tan J; Stub D; Tamburino C; Lange R; Leipsic J Catheter Cardiovasc Interv; 2015 Sep; 86(3):508-15. PubMed ID: 25573784 [TBL] [Abstract][Full Text] [Related]